Mirador Capital Partners LP 10x Genomics, Inc. Transaction History

Mirador Capital Partners LP

$597 Million
Q2 2025

A detailed history of Mirador Capital Partners LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 79,443 shares of TXG stock, worth $989,065. This represents 0.15% of its overall portfolio holdings.

Number of Shares

79,443

Previous 80,257 1.01%

Holding current value

$989,065

Previous $700,000 31.29%

% of portfolio

0.15%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	SELL	$7.14 - $11.73 $5,811 - $9,548	-814 Reduced 1.01%	79,443 $919,000
Q1 2025 Apr 08, 2025	SELL	$8.73 - $16.31 $6,337 - $11,841	-726 Reduced 0.9%	80,257 $700,000
Q4 2024 Jan 14, 2025	BUY	$13.18 - $21.31 $300,398 - $485,697	22,792 Added 39.17%	80,983 $1.16 Million
Q3 2024 Oct 04, 2024	SELL	$15.71 - $23.49 $59,320 - $88,698	-3,776 Reduced 6.09%	58,191 $1.31 Million
Q2 2024 Jul 12, 2024	BUY	$19.45 - $37.37 $644,611 - $1.24 Million	33,142 Added 114.98%	61,967 $1.21 Million
Q1 2024 Apr 17, 2024	BUY	$36.08 - $54.3 $33,915 - $51,042	940 Added 3.37%	28,825 $1.08 Million
Q4 2023 Jan 19, 2024	BUY	$34.32 - $57.55 $17,880 - $29,983	521 Added 1.9%	27,885 $1.56 Million
Q3 2023 Oct 05, 2023	SELL	$40.86 - $62.98 $183,052 - $282,150	-4,480 Reduced 14.07%	27,364 $1.13 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $61,406 - $70,757	-1,205 Reduced 3.65%	31,844 $1.78 Million
Q1 2023 Apr 14, 2023	BUY	$35.33 - $55.79 $228,867 - $361,407	6,478 Added 24.38%	33,049 $1.84 Million
Q4 2022 Feb 09, 2023	SELL	$24.4 - $41.3 $41,724 - $70,623	-1,710 Reduced 6.05%	26,571 $968,000
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $358,477 - $661,950	12,587 Added 80.2%	28,281 $805,000
Q2 2022 Aug 05, 2022	SELL	$36.95 - $82.41 $231,048 - $515,309	-6,253 Reduced 28.49%	15,694 $710,000
Q1 2022 May 06, 2022	BUY	$55.7 - $145.79 $25,844 - $67,646	464 Added 2.16%	21,947 $1.67 Million
Q4 2021 Feb 02, 2022	BUY	$135.05 - $182.59 $182,722 - $247,044	1,353 Added 6.72%	21,483 $3.2 Million
Q3 2021 Nov 09, 2021	BUY	$145.58 - $192.14 $657,876 - $868,280	4,519 Added 28.95%	20,130 $2.93 Million
Q2 2021 Jul 27, 2021	BUY	$134.22 - $202.37 $191,263 - $288,377	1,425 Added 10.05%	15,611 $3.06 Million
Q1 2021 Apr 29, 2021	SELL	$140.25 - $196.86 $26,787 - $37,600	-191 Reduced 1.33%	14,186 $2.57 Million
Q4 2020 Jan 20, 2021	BUY	$126.47 - $163.7 $118,628 - $153,550	938 Added 6.98%	14,377 $2.04 Million
Q3 2020 Nov 12, 2020	BUY	$87.44 - $125.0 $51,414 - $73,500	588 Added 4.58%	13,439 $1.68 Million
Q2 2020 Aug 06, 2020	BUY	$58.39 - $89.31 $32,523 - $49,745	557 Added 4.53%	12,851 $1.15 Million
Q1 2020 May 11, 2020	BUY	$51.57 - $106.62 $412,250 - $852,320	7,994 Added 185.91%	12,294 $968,000
Q4 2019 Jan 17, 2020	BUY	$46.07 - $79.54 $198,101 - $342,022	4,300 New	4,300 $328,000

Others Institutions Holding TXG

# of Institutions

302

Shares Held

109M

Call Options Held

228K

Put Options Held

157K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.18B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Account

Mirador Capital Partners LP 10x Genomics, Inc. Transaction History